Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - OTHER LONG-TERM ASSETS
Other Long-term Assets EXEL - Exelixis, Inc.
637 M
LAST VALUE
0.00%
2 YEAR CAGR
123.96%
5 YEAR CAGR
47.56%
10 YEAR CAGR